Forbes October 25, 2024
Alex Knapp

Plus: A new class of materials for carbon capture, Blue Origin’s new spaceship and the science-approved way to throw a frisbee.

Abortion is one of the major policy issues in this current election cycle. And one point of debate is mifepristone, a drug that’s commonly administered to induce abortions during the early stages of a pregnancy. Attorneys general in Idaho, Kansas and Missouri filed a lawsuit against the FDA last week aiming to roll back regulations that allowed the drug to be prescribed during a telehealth appointment.

But mifepristone isn’t only used for abortions. It’s also used as a treatment for patients with Cushing’s syndrome and is being tested as a treatment for other diseases. And new research published this...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Patient / Consumer, Provider
Wearable device uses bioimpedance to track joint swelling and damage
FOLX Health focuses on whole person care for LGBTQIA+ patients
Cancer in America: Disturbing findings for women and Black Americans
Opinion: STAT+: How the FDA and CMS worked together on a new approach to paying for digital mental health treatments
The Quintuple Aim: Redefining Patient-Centered Care in the Digital Age

Share This Article